Thus, in our analysis, we found that pre-COVID-19 dengue patients exhibited significantly higher levels of antithrombin and plasminogen than post-COVID-19 dengue patients, suggesting a potentially more anticoagulant and profibrinolytic profile in the earlier cohort. The gene discussed is PLG; the disease is dengue disease.